Boothbay Fund Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-80,000
Closed -$15.4M 2197
2023
Q2
$15.4M Buy
+80,000
New +$15.9M 0.34% 37
2023
Q1
Sell
-35,600
Closed -$4.57M 2615
2022
Q4
$4.57M Buy
35,600
+900
+3% +$116K 0.11% 262
2022
Q3
$4.75M Sell
34,700
-8,400
-19% -$1.37M 0.12% 205
2022
Q2
$7.63M Buy
+43,100
New +$6.21M 0.2% 78
2019
Q2
Sell
-392
Closed -$2.87M 939
2019
Q1
$2.87M Buy
+392
New +$27.9K 0.28% 82

Other funds holding SGEN

Boothbay Fund Management's SGEN Position: Q4 2023 in Review

Boothbay Fund Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 47,000 shares — an estimated $9.97M sold.

Boothbay Fund Management first reported a position in SGEN in Q3 2022 and held it in 4 quarters. The position peaked at $9.97M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Boothbay Fund Management reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 47,000 Seagen Inc. Common Stock shares in Q4 2023, an estimated $9.97M.
  • Boothbay Fund Management first reported a position in Seagen Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Boothbay Fund Management's Seagen Inc. Common Stock position peaked at $9.97M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Boothbay Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.